XKRX
123690
Market cap76mUSD
Oct 08, Last price
6,380.00KRW
1D
-3.19%
1Q
-1.39%
Jan 2017
-49.57%
IPO
61.52%
Name
Hankook Cosmetics Co Ltd
Chart & performance
P/E
90.95
P/S
1.20
EPS
70.15
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
3.29%
Revenues
85.24b
-8.13%
Net income
1.13b
-75.46%
CFO
2.91b
-7.19%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hankook Cosmetics Co., Ltd. operates as an international beauty company, specializing in the manufacturing and sale of various cosmetic products within South Korea and across global markets. The firm offers a comprehensive portfolio, distributing its items under a diverse range of brands such as Sansim, Hyoum, Ossion, Jutanhak, Secret Nature, Calli, GENERTE, A3F[on], Temptation, CONTINUE, Chess The Classic, CLASSYGIRL, Beautri, BEAUTENIQUE, Dr Medix, and Parapam. Established in 1961, its main office is situated in Seoul, South Korea.
Key people
Vice President · since 2021
Hong Yin Jang
Internal Auditor
Director
Chief Executive Officer, Vice Chairman of the Board · since 2021
Director
Seong Dong Kim
Non-Executive Independent Director · since 2022
Ja Yeong Lee
Non-Executive Independent Director
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||